Highly Controlled Diffusion Drug Release from Ureasil-Poly(ethylene oxide)-Na+-Montmorillonite Hybrid Hydrogel Nanocomposites

Antiswelling, Ultrastretchable, and Ultrastable Hydrogel Sensors for Long-Term Underwater Monitoring

Wearable strain sensors designed for underwater environments and monitoring users' health status and safety are highly desirable. However, constructing antiswelling, stretchable, and stable hydrogel strain sensors for prolonged underwater monitoring is still a great challenge. In this work, conductive hydrogel sensors suitable for comprehensive environmental monitoring are developed by integrating conductive montmorillonite (MMT) into hydrogels. The conductive hydrogels demonstrate exceptional stretchability, elasticity, electrical conductivity, a wide operational range, and high sensing accuracy. Additionally, the sensors exhibit excellent underwater stability, making them suitable for use in underwater communication and alert systems. The conductive hydrogels developed herein present a novel pathway for advancing underwater sensing applications, human-robot interaction, soft robotics, and underwater intelligent devices.

Functionalized hydrogels as smart gene delivery systems to treat musculoskeletal disorders

Despite critical advances in regenerative medicine, the generation of definitive, reliable treatments for musculoskeletal diseases remains challenging. Gene therapy based on the delivery of therapeutic genetic sequences has strong value to offer effective, durable options to decisively manage such disorders. Furthermore, scaffold-mediated gene therapy provides powerful alternatives to overcome hurdles associated with classical gene therapy, allowing for the spatiotemporal delivery of candidate genes to sites of injury. Among the many scaffolds for musculoskeletal research, hydrogels raised increasing attention in addition to other potent systems (solid, hybrid scaffolds) due to their versatility and competence as drug and cell carriers in tissue engineering and wound dressing. Attractive functionalities of hydrogels for musculoskeletal therapy include their injectability, stimuli-responsiveness, self-healing, and nanocomposition that may further allow to upgrade of them as "intelligently" efficient and mechanically strong platforms, rather than as just inert vehicles. Such functionalized hydrogels may also be tuned to successfully transfer therapeutic genes in a minimally invasive manner in order to protect their cargos and allow for their long-term effects. In light of such features, this review focuses on functionalized hydrogels and demonstrates their competence for the treatment of musculoskeletal disorders using gene therapy procedures, from gene therapy principles to hydrogel functionalization methods and applications of hydrogel-mediated gene therapy for musculoskeletal disorders, while remaining challenges are being discussed in the perspective of translation in patients. STATEMENT OF SIGNIFICANCE: Despite advances in regenerative medicine, the generation of definitive, reliable treatments for musculoskeletal diseases remains challenging. Gene therapy has strong value in offering effective, durable options to decisively manage such disorders. Scaffold-mediated gene therapy provides powerful alternatives to overcome hurdles associated with classical gene therapy. Among many scaffolds for musculoskeletal research, hydrogels raised increasing attention. Functionalities including injectability, stimuli-responsiveness, and self-healing, tune them as "intelligently" efficient and mechanically strong platforms, rather than as just inert vehicles. This review introduces functionalized hydrogels for musculoskeletal disorder treatment using gene therapy procedures, from gene therapy principles to functionalized hydrogels and applications of hydrogel-mediated gene therapy for musculoskeletal disorders, while remaining challenges are discussed from the perspective of translation in patients.

The Development and Pre-Clinical Anti-Inflammatory Efficacy of a New Transdermal Ureasil-Polyether Hybrid Matrix Loaded with Flavonoid-Rich Annona muricata Leaf Extract

This study aimed to develop a novel ureasil-polyether transdermal hybrid matrix (U-PEO) loaded with Annona muricata concentrated extract (AMCE), which exhibits potent anti-inflammatory activity. The extract was obtained by maceration, a method that allowed for the extraction of a high concentration of flavonoids (39.27 mg/g of extract). In vivo tests demonstrated that 10 mg/kg of AMCE inhibited inflammation for 6 h. The physicochemical characterization of U-PEO with AMCE was conducted via a thermogravimetric analysis (TGA), while its surface was recorded using atomic force microscopy (AFM). The in vitro macroscopic swelling and release tests demonstrated the hydrophilic profile of the material and the percentage of AMCE released. The TGA results demonstrated that the system exhibited physical compatibility due to the thermal stability of U-PEO. Additionally, the AFM analysis revealed a rough and porous surface, with a particular emphasis on the system with AMCE. The release resulted in the liberation of 23.72% of AMCE within 24 h. Finally, the preclinical tests demonstrated that U-PEO with AMCE was also capable of effectively inhibiting inflammation for 6 h, a duration comparable to that of a commercial formulation. The results permit the advancement of the study towards the development of a transdermal system, thereby rendering its application in clinical studies feasible.

A pseudo-Double-Network Hydrogel Built upon Layered Double Hydroxides with Self-Strengthening Properties

While great achievements have been made in the development of mechanically robust nanocomposite hydrogels, incorporating multiple interactions on the bases of two demensional inorganic cross-linkers to construct self-strengthening hydrogels has rarely been investigated. To this end, we propose here a new method for the coupling the dynamic covalent bonds and non-covalent interactions within a pseudo double-network system. The pseudo first network, formed through the Schiff Base reation between Tris-modified layered double hydroxides (Tris-LDHs) and oxidized dextran (ODex), is linked to the second network built upon non-covalent interactions between Tris-LDHs and poly(acrylamide-co-2-acrylamido-2-methyl-propanesulfonate) (p-(AM-co-AMPS). The swelling and mechanical properties of the resulting hydrogels have been investigated as a function of the ODex and AMPS contents. The as-prepared hydrogel can swell to 420 times of its original size and retain more than 99.9 wt.% of water. Mechanical tests show that the hydrogel can bear 90 % of compression and is able to be stretched to near 30 times of its original length. Cyclic tensile tests reveal that the hydrogels are capable of self-strengthening after mechanical training. The unique energy dissipation mechanism based on the dynamic covalent and non-covalent interactions is considered to be responsible for the outstanding swelling and mechanical performances.

Gout therapeutics and drug delivery

Gout is a common inflammatory arthritis caused by persistently elevated uric acid levels. With the improvement of people's living standards, the consumption of processed food and the widespread use of drugs that induce elevated uric acid, gout rates are increasing, seriously affecting the human quality of life, and becoming a burden to health systems worldwide. Since the pathological mechanism of gout has been elucidated, there are relatively effective drug treatments in clinical practice. However, due to (bio)pharmaceutical shortcomings of these drugs, such as poor chemical stability and limited ability to target the pathophysiological pathways, traditional drug treatment strategies show low efficacy and safety. In this scenario, drug delivery systems (DDS) design that overcome these drawbacks is urgently called for. In this review, we initially describe the pathological features, the therapeutic targets, and the drugs currently in clinical use and under investigation to treat gout. We also comprehensively summarize recent research efforts utilizing lipid, polymeric and inorganic carriers to develop advanced DDS for improved gout management and therapy.

Layered Clay Minerals in Cancer Therapy: Recent Progress and Prospects

Cancer is one of the deadliest diseases, and current treatment regimens suffer from limited efficacy, nonspecific toxicity, and chemoresistance. With the advantages of good biocompatibility, large specific surface area, excellent cation exchange capacity, and easy availability, clay minerals have been receiving ever-increasing interests in cancer treatment. They can act as carriers to reduce the toxic side effects of chemotherapeutic drugs, and some of their own properties can kill cancer cells, etc. Compared with other morphologies clays, layered clay minerals (LCM) have attracted more and more attention due to adjustable interlayer spacing, easier ion exchange, and stronger adsorption capacity. In this review, the structure, classification, physicochemical properties, and functionalization methods of LCM are summarized. The state-of-the-art progress of LCM in antitumor therapy is systematically described, with emphasis on the application of montmorillonite, kaolinite, and vermiculite. Furthermore, the property-function relationships of LCM are comprehensively illustrated to reveal the design principles of clay-based antitumor systems. Finally, foreseeable challenges and outlook in this field are discussed.

Effect of Organomontmorillonite-Cloisite® 20A Incorporation on the Structural and Drug Release Properties of Ureasil-PEO Hybrid

This paper presents the influence of the presence of a modified organoclay, Cloisite^® 20A (MMTA) on the structural and drug release properties of ureasil organic-inorganic hybrid. Sol-gel process was used to prepare the hybrid nanocomposites containing sodium diclofenac (DCF) at 5% wt. The effect of the amount of MMTA incorporated into the ureasil hybrid matrix was evaluated and characterized in depth by different techniques such as X-ray diffraction (XRD), small angle X-ray scattering (SAXS), differential scanning calorimetry (DSC), and swelling properties. The influence of MMTA on ureasil nanocomposites release profile was evaluated by in situ UV-vis. The diffraction patterns of the UPEO-MMTA nanocomposites showed a synergistic contribution effect that led to an intensity increase and narrowed the diffraction peaks, evidencing a crystallite PEO growth as a function of the modified nanoclay content. The interactions between polyether chains and the hydrogenated tallow of MMTA led to an easy intercalation process, as observed in UPEO-MMTA nanocomposites containing low (1% wt) or high (20% wt) nanoclay content. The waterway (channels) created in UPEO-MMTA nanocomposites contributed to a free volume increase in the swollen network compared to UPEO without MMTA. The hypothesis of the channels created after intercalation of the PEO phase in the interlayer of MMTA containing organoammonium ions corroborates with the XRD results, swelling studies by SAXS, and release assays. Furthermore, when these clay particles were dispersed in the polymeric matrix by an intercalation process, water uptake improvement was observed, with an increased amount of DCF release. The design of ureasil-MMTA nanocomposites containing modified nanoclay endows them with tunable properties; for example, swelling degree followed by amount of controlled drug release, opening the way for more versatile biomedical applications.

One-pot self-assembly fabrication of chitosan coated hollow sphere for pH/ glutathione dual responsive drug delivery

Chitosan-coated poly (methacrylic acid) (PMAA) hollow spheres with 64 ± 3% drug loading capacity and low drug leakage (7 ± 2%, 54 h) were prepared through a novel one-pot two-step self-assembly process. Site-specific doxorubicin (DOX) loading and chitosan coating were achieved by electrostatic interaction to fulfill efficient drug loading and well-controlled drug release behavior. In vitro drug release profile revealed the pH and glutathione (GSH) dual responsive fast triggered drug release behavior, reaching 62 ± 3% during the first 10 h. And completely drug release could be achieved in 54 h. The high drug content and sensitive tumor microenvironment responsibility lead to similar anti-cancer efficiency with free doxorubicin in in vitro MTT assay. This self-assembly guided one-pot two-step fabrication process was proved to be an effective and convenient way to prepare the well-defined multi-layer structure and might be further employed in fabricating high-performance drug delivery systems.

Development of Cationic Cellulose-Modified Bentonite-Alginate Nanocomposite Gels for Sustained Release of Alachlor

The nanocomposite gel prepared from nanoclay and natural polysaccharides showed a good sustained-release property. Herein, a cationic cellulose-modified bentonite-alginate nanocomposite gel was prepared and used to enhance the sustained release of alachlor. The underlying effect and mechanism of the structure of modified bentonite-alginate nanocomposite gels on the release behavior of alachlor were explored by Fourier transform infrared (FTIR) spectroscopy, X-ray diffraction (XRD), scanning electron microscopy (SEM), and thermogravimetric (TG) analysis. The results showed that the release of alachlor from the nanocomposite gels was dominated by Fickian diffusion and closely related to the adsorption capacity and permeability of the matrix. The cationic cellulose intercalated into the interlayer space of bentonite through an ion exchange reaction, which significantly enhanced the hydrophobicity of bentonite and its interaction with alachlor. The stacking aggregation of bentonite nanoplatelets and permeability of the gel network were decreased through the electrostatic interaction between cationic cellulose and alginate molecular chains, thus remarkably enhancing the sustained-release property of the nanocomposite gel. The release kinetics revealed that the release rate of alachlor from the nanocomposite gel first decreased and then increased as the content of bentonite and modified bentonite gradually increased. Also, the best sustained-release property of the nanocomposite gel was obtained at bentonite and modified bentonite additions of about 10%, under which the release time of 50% alachlor (T ₅₀) from bentonite-alginate and modified bentonite-alginate nanocomposite gels was 4.4 and 5.6 times longer than the release time from pure alginate gels, respectively.

Magnetic κ-carrageenan/chitosan/montmorillonite nanocomposite hydrogels with controlled sunitinib release

This work aimed to design montmorillonite-incorporated pH-responsive and magnetic κ-carrageenan/chitosan hydrogels via a completely green route for controlled release of sunitinib anticancer drug. This was accomplished by ionic cross-linking of two biopolymers, κ-carrageenan and chitosan, in the presence of magnetic montmorillonite (mMMt) nanoplatelets. Interestingly, it was observed that the amount of mMMt affected not only the microstructure of hydrogels, but also the drug loading efficiency of nanocomposite hydrogels was noticeably increased by introducing mMMt (from 69 to 96%). The in vitro sunitinib release experiments showed that a low content of loaded sunitinib was released from all hydrogels in the buffered solution with pH 7.4. In contrast, a relatively sustained release with a high content of drug release was observed in the acidic solution of pH 5.5. During 48 h, the hydrogels nanocomposite containing a high content of mMMt showed cumulative release of 64.0 and 8.6% at pH 5.5 and 7.4, respectively. During two days, while the cumulative release of sunitinib was obtained 84.3% for the magnetic-free hydrogel, the magnetic ones showed 74.4 and 64% with the low and high contents of magnetic MMt, respectively. The developed κ-carrageenan/chitosan hydrogels with a high capacity of drug loading and subsequent pH-sensitive drug release can be considered in prolonged cancer therapy with reduced side effects.

Surface Laser-Marking and Mechanical Properties of Acrylonitrile-Butadiene-Styrene Copolymer Composites with Organically Modified Montmorillonite

In this study, organically modified montmorillonite (OMMT) was prepared by modifying MMT with a cationic surfactant cetyltrimethylammonium bromide (CTAB). The obtained OMMT of different loading contents (1, 2, 4, 6, and 8 wt %) was melt-blended with poly(acrylonitrile-co-butadiene-co-styrene) (ABS) to prepare a series of ABS/OMMT composites, which were laser marked using a neodymium-doped yttrium aluminum garnet (Nd:YAG) laser beam of 1064 nm under different laser current processes. X-ray diffraction (XRD), color difference spectrometer, optical microscope, water contact angle tests, scanning electron microscope (SEM), and Raman spectroscopy were carried out to characterize the morphology, structure, and properties of the laser-patterned ABS composites. The effects of the addition of OMMT and the laser marking process on the mechanical properties of ABS/OMMT composites were investigated through mechanical property tests. The results show that the obtained ABS/OMMT composites have enhanced laser marking performance, compared to the ABS. When the OMMT content is 2 wt % and the laser current intensity is 9 A, the marking on ABS composites has the highest contrast (ΔE = 36.38) and sharpness, and the quick response (QR) code fabricated can be scanned and identified with a mobile app. SEM and water contact angle tests showed that the holes, narrow cracks, and irregular protrusion are formed on the composite surface after laser marking, resulting in a more hydrophobic surface and an increased water contact angle. Raman spectroscopy and XRD indicate that OMMT can absorb the near-infrared laser energy, undergo photo thermal conversion, and cause the pyrolysis and carbonization of ABS to form black marking, and the crystal structure itself does not change significantly. When the 2 wt % of OMMT is loaded, the tensile strength, elongation at break, and impact strength of ABS/OMMT are increased by 15, 20, and 14%, respectively, compared to ABS. Compared with the unmarked ABS/OMMT, the defects including holes and cracks generated on the surface of the marked one lead to the decreased mechanical property. The desirable combination of high contrast laser marking performance and mechanical properties can be achieved at an OMMT loading content of 2 wt % and a laser current intensity of 9 A. This research work provides a simple, economical, and environmentally friendly method for laser marking of engineering materials such as ABS.

Structure Regulation of Bentonite-Alginate Nanocomposites for Controlled Release of Imidacloprid

To reveal the structure and release properties of bentonite-alginate nanocomposites, bentonite of different amounts was incorporated into alginate by the sol-gel route. The structure of the composites was characterized by Fourier transform infrared spectroscopy, X-ray diffraction, scanning electron microscopy, and thermogravimetric analysis and related to the swelling property of the matrix and the release of imidacloprid. Bentonite was subject to exfoliation into nanoplatelets and combined into the polymeric network within alginate hydrogel, exhibiting profound effects on the structure features and release properties of the composites. Bentonite was of good compatibility with alginate due to the hydrogen bonding and the electrostatic attraction between them. The polymer chains were found to intercalate into the interlayer gallery of the clay. The high specific area of the nanoplatelets of bentonite benefited the intimate contact with alginate and reduced the permeability of the composites. However, in the composites with clay content of more than 10%, the polymer was insufficient to accommodate the silicate sheets completely. The aggregation of the platelets destroyed the structure integrity of the composites, facilitating the diffusion of the pesticide. The release of imidacloprid was greatly retarded by incorporating into bentonite-alginate composites and dominated by Fickian diffusion depending on the permeability of the matrix. The time taken for 50% of the active ingredient to be released, T 50, first increased and then decreased with increasing clay content in the composites, reaching a maximum around a weight percentage of 10%, at which the T 50 value for imidacloprid release was about 2.5 times that for the release from pure alginate formulation.

A Fluorescent DNA Hydrogel Aptasensor Based on the Self-Assembly of Rolling Circle Amplification Products for Sensitive Detection of Ochratoxin A

A sensitive fluorescent DNA hydrogel aptasensor based on the self-assembly of rolling circle amplification (RCA) products was developed for ochratoxin A (OTA) detection in beer. A competitive binding mode of aptamer, complementary sequence, and target was integrated into the DNA hydrogel for OTA detection. The OTA aptamer first combined with the primer to form the hybridized product. Then, in the presence of OTA, the aptamer combined with OTA, which released the primer. The released primer hybridized with the padlock probe to form a circular template, and the RCA reaction was initiated by adding ligase, polymerase, and dNTPs. The fluorescent DNA hydrogel was obtained by adding Cy3-dUTP together with dNTPs, and the fluorescence (FL) intensity of the DNA hydrogel was positively correlated with OTA concentration. Under the optimal experimental conditions, the linear range of the relationship varied from 0.05 ng/mL to 100 ng/mL with a detection limit for OTA of 0.01 ng/mL. The fluorescent DNA hydrogel aptasensor showed good specificity and stability in beer samples. Therefore, the fabricated DNA hydrogel aptasensor shows considerable potential applications in detecting OTA for food safety.

Clay-Polymer Nanocomposites Prepared by Reactive Melt Extrusion for Sustained Drug Release

Abstract: Clay-polymer nanocomposites have exhibited a great potential as carriers for controlled release drug delivery. This study aims to prepare exfoliated montmorillonite-Eudragit RS nanocomposites using reactive melt extrusion and investigate the influence of claying loading, clay types (sodium montmorillonite (Cloisite Na) vs. organomodified montmorillonite (Cloisite 20)) on clay-polymer interactions and drug release properties. The clays were used as the filler material at various levels in Eudragit RS and theophylline was used as the active pharmaceutical ingredient. The resulting structure of the nanocomposites was characterized using TEM (transmission electron microscopy) and XRPD (X-ray powder diffraction). The hygroscopicity of the nanocomposites was investigated using DVS (dynamic vapor sorption). The effect of the interfacial interaction between the polymer and clay sheet, the clay loading as well as the clay type on the drug release behavior were further studied by dissolution testing. TEM and XRPD data show that when the clay content is increased from 5% to 15% by weight, the nanocomposite's structure switches from a fully exfoliated state to intercalated structures or partial exfoliation with stacked clay layers. FT-IR (fourier transform infrared spectroscopy) and ssNMR (solid-state NMR) results suggest that Cloisite Na and Cloisite 20 layers exhibit different interaction strengths with polymer networks by creating compacted complex structures. The addition of nanoclay in the formulation could robustly adjust drug release profiles, and the clay concentration and type are important factors that affect the crossing-linking density of the nanocomposites by adjusting the drug release properties. This study indicates that the clay-Eudragit RS nanocomposites provide an improved oral controlled drug delivery system that minimizes the drug dosing frequency, potentially leading to improved patient compliance.

Montmorillonite-based polyacrylamide hydrogel rings for controlled vaginal drug delivery

Vaginal drug delivery is regarded as a promising route against women-related health issues such as unwanted pregnancies and sexually transmitted infections. However, only a very few studies have been reported on the use of hydrogel rings with low cytotoxicity for vaginal drug delivery applications. Moreover, the effect of nanoparticles on hydrogel vaginal rings has not been clearly evaluated. To overcome these challenges, we hereby developed nanocomposite hydrogel rings based on polyacrylamide-sodium carboxymethyl cellulose-montmorillonite nanoparticles in the ring-shaped aluminum mold for controlled drug delivery. The hydrogel rings were synthesized by using N,N'-methylene bisacrylamide, N,N,N',N'-tetramethyl ethylene diamine, and ammonium persulfate, as a crosslinker, accelerator, and initiator, respectively. The obtained rings were 5.5 cm in diameters and 0.5 cm in rims. Chemical structures of the nanocomposite rings were confirmed by Fourier transform infrared, and Nuclear Magnetic Resonance spectroscopies. Additionally, the swelling ratio of hydrogels was appeared to be adjusted by the introduction of nanoparticles. In vitro release experiment of methylene blue, as a hydrophilic model drug, revealed that the nanocomposite rings could not only reduce burst effect (almost more than twice), but also achieve prolonged release for 15 days in the vaginal fluid simulant which mimic the vaginal conditions at pH of almost 4.2, and a temperature of 37 °C. Importantly, the resultant hydrogel rings with or without various concentrations of montmorillonite showed low cytotoxicity toward human skin fibroblasts. Furthermore, different antibacterial activities against Escherichia coli were observed for various concentrations of montmorillonite in hydrogels. These results suggest the great potential of montmorillonite-based hydrogel rings for vaginal drug delivery.

Recent developments in the use of organic-inorganic nanohybrids for drug delivery

Organic-inorganic nanohybrid (OINH) structures providing a versatile platform for drug delivery with improved characteristics are an area which has gained recent attention. Much effort has been taken to develop these structures to provide a viable treatment options for much alarming diseases such as cancer, bone destruction, neurological disorders, and so on. This review focuses on current work carried out in producing different types of hybrid drug carriers identifying their properties, fabrication techniques, and areas where they have been applied. A brief introduction on understating the requirement for blending organic-inorganic components into a nanohybrid drug carrier is followed with an elaboration given about the different types of OINHs developed currently highlighting their properties and applications. Then, different fabrication techniques are discussed given attention to surface functionalization, one-pot synthesis, wrapping, and electrospinning methods. Finally, it is concluded by briefing the challenges that are remaining to be addressed to obtain multipurpose nanohybrid drug carriers with wider applicability. This article is categorized under: Therapeutic Approaches and Drug Discovery > Emerging Technologies.

Two-dimensional nanomaterials: fascinating materials in biomedical field

Due to their high anisotropy and chemical functions, two-dimensional (2D) nanomaterials have attracted increasing interest and attention from various scientific fields, including functional electronics, catalysis, supercapacitors, batteries and energy materials. In the biomedical field, 2D nanomaterials have made significant contributions to the field of nanomedicine, especially in drug/gene delivery systems, multimodal imaging, biosensing, antimicrobial agents and tissue engineering. 2D nanomaterials such as graphene/graphene oxide (GO)/reduced graphene oxide (rGO), silicate clays, layered double hydroxides (LDHs), transition metal dichalcogenides (TMDs), transition metal oxides (TMOs), black phosphorus (BP), graphitic carbon nitride (g-C₃N₄), hexagonal boron nitride (h-BN), antimonene (AM), boron nanosheets (B NSs) and tin telluride nanosheets (SnTe NSs) possess excellent physical, chemical, optical and biological properties due to their uniform shapes, high surface-to-volume ratios and surface charge. In this review, we first introduce the properties, structures and synthetic strategies of different configurations of 2D nanomaterials. Recent advances and paradigms of 2D nanomaterials in a variety of biomedical applications, ranging from drug delivery, cancer treatment, bioimaging and tissue engineering to biosensing are discussed afterwards. In the final part, we foresee the development prospects and challenges of 2D nanomaterials after summarizing the research status of ultrathin 2D nanomaterials.

Quaternized Chitosan-Coated Montmorillonite Interior Antimicrobial Metal-Antibiotic in Situ Coordination Complexation for Mixed Infections of Wounds

Conventional drug delivery systems for natural clay materials still face critical challenges in their practical application, including multiple bacterial infections, combined infection of bacteria and fungi, and low sterilization efficiency. In this work, we address these challenges using the multifunctional montmorillonite nanosheet-based (MMT-based) drug nanoplatform, which involves the antibiotic 5-fluorocytosine (5-FC), antibacterial metal copper ions, and quaternized chitosan (QCS). Composite material QCS/MMT/5-FCCu can can strongly inhibit Staphylococcus aureus (a typical Gram-positive bacterium), Escherichia coli (a typical Gram-negative bacterium), and Candida albicans (a fungus) because 5-FC coordinates with copper ions in situ and due to the deposition of QCS. The subsequent drug release behavior of 5-FCCu was studied, and the results show an initial high concentration kills microorganisms and long-acting sustained release inhibition. Moreover, in vivo wound experiments and toxicity experiments show the promotion of wound healing and excellent biocompatibility. As a demonstration of the utility of the latter, we have shown that the MMT-based smart platform can be used for the treatment of mixed infections of wounds.

Coupling Photoluminescence and Ionic Conduction Properties Using the Different Coordination Sites of Ureasil-Polyether Hybrid Materials

In this article, we demonstrate that each functional group of ureasil organic-inorganic hybrid (OIH) materials can act as a specific coordination site for a given active guest species, hence allowing the possibility of combining different functional properties. To illustrate this concept, the sol-gel process was used to produce diurea cross-linked siloxane-polyethylene oxide (U-PEO) and siloxane-polypropylene oxide (U-PPO) hybrid host frameworks with similar molecular weights (1900 and 2000 g mol^-1 for PEO and PPO, respectively), with Li⁺ and Eu³⁺ as active guest ions providing ionic conduction and photoluminescence (PL) properties, respectively. Comparison of Fourier transform infrared spectra and small-angle X-ray scattering results for single-doped (using Li⁺ or Eu³⁺) and co-doped (using Li⁺ and Eu³⁺) U-PEO and U-PPO hosts showed that in every case, there was specific coordination of Eu³⁺ by the carbonyl group of the urea bridge and of Li⁺ by ether-type oxygen of the PEO and PPO chains. Optical analyses demonstrated that loading with Li⁺ did not affect the luminescence properties of the Eu³⁺-loaded OIH. Although loading with Eu³⁺ had a small effect on ionic transport, co-doping with Li⁺ ions ensured macroscopic ion-conduction of the transparent and luminescent hybrid material. The results suggested that the combination of both properties in a transparent elastomeric material could be useful for the development of multifunctional devices. The results suggested that the combination of both properties in a transparent elastomeric material could be useful for the development of multifunctional polyelectrolytes applied in the field of dual luminescent devices such as photoelectrochromic smart windows.